BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15009090)

  • 1. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
    Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
    J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
    Wang Y; Wang J; Gao L; Lafyatis R; Stamm S; Andreadis A
    J Biol Chem; 2005 Apr; 280(14):14230-9. PubMed ID: 15695522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.
    Wu JY; Kar A; Kuo D; Yu B; Havlioglu N
    Mol Cell Biol; 2006 Sep; 26(18):6739-47. PubMed ID: 16943417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
    Chew SL; Liu HX; Mayeda A; Krainer AR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55.
    Nagel RJ; Lancaster AM; Zahler AM
    RNA; 1998 Jan; 4(1):11-23. PubMed ID: 9436904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.
    Hasegawa M; Smith MJ; Iijima M; Tabira T; Goedert M
    FEBS Lett; 1999 Jan; 443(2):93-6. PubMed ID: 9989582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRp30c is a repressor of 3' splice site utilization.
    Simard MJ; Chabot B
    Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.
    Hartmann AM; Rujescu D; Giannakouros T; Nikolakaki E; Goedert M; Mandelkow EM; Gao QS; Andreadis A; Stamm S
    Mol Cell Neurosci; 2001 Jul; 18(1):80-90. PubMed ID: 11461155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.
    Stoilov P; Daoud R; Nayler O; Stamm S
    Hum Mol Genet; 2004 Mar; 13(5):509-24. PubMed ID: 14709600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.